Journals / Pediatric Practice and Research / 2020 / Cilt: 8 - Sayı: 3

Serum Sickness Like Disease in Children

Çocuklarda Serum Hastalığı Benzeri Reaksiyonlar

Pages
116–121
Publication Date
2020-12-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Recommended or achieved a consensus for the treatment of the serum sickness-like reaction doesn’t occur and the information about this subject in the literature is limited by the authors’ case reports who share their experiences.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serum sickness and serum sickness-like reactions are the type 3 hypersensitivity reactions that occur in the presence of culprit agents which can be an exogenous protein, drug, bacteria, virus.
📊
Key Findings & Data:Clinical symptoms usually begin in 6-21 days after exposure to antigenic stimulation.
💡
Conclusion & Impact:Recommended or achieved a consensus for the treatment of the serum sickness-like reaction doesn’t occur and the information about this subject in the literature is limited by the authors’ case reports who share their experiences.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:çocuk · döküntü · hipersensitivite

Abstract

Serum sickness and serum sickness-like reactions are the type 3 hypersensitivity reactions that occur in the presence of culprit agents which can be an exogenous protein, drug, bacteria, virus. Clinical symptoms usually begin in 6-21 days after exposure to antigenic stimulation. Typical clinical findings are characterised as fever (10-20%), erythematous rash (95%), polyarthritis and / or polyarthralgia (10-50%), and lymphadenopathy (10-20%). There are no specific laboratory findings and diagnostic criteria for serum sickness-like reaction. Laboratory findings usually include leukocytosis, mildly increased erythrocyte sedimentation rate, and rarely proteinuria and hematuria. Even though there are no diagnostic criteria for serum sickness-like reaction, it can be diagnosed with the presence of fever, rash, arthritis-arthralgia, lymphadenopathy, myalgia which occurs in 1-2 weeks after exposure to an agent that can trigger the disease. Recommended or achieved a consensus for the treatment of the serum sickness-like reaction doesn’t occur and the information about this subject in the literature is limited by the authors’ case reports who share their experiences.

Özet

Serum hastalığı ve serum hastalığı benzer reaksiyonlar belli antijenlerin varlığında ortaya çıkan tip III hipersensitivite reaksiyonudur. Semptomlar antijenik uyarıya maruziyet sonrası genelde 6-21 gün sonra başlar. Tip III hipersensitivite reaksiyonuna sebep olan antijen ekzojen yabancı bir protein, ilaç, bakteri, virüs olabilir. Tipik klinik bulgular ateş (%10-20), eritamatöz döküntü (%95), poliartrit ve/veya poliartralji (%10-50) ve lenfadenopati (%10-20) ile karakterizedir. Serum hastalığı benzeri reaksiyon için spesifik labaratuvar bulguları ve tanı kriteri bulunmamaktadır. Labaratuvar bulgularında genellikle lökositoz, hafif artmış eritrosit sedimentasyon hızı ve nadiren proteinüri ve hematüriyi içermektedir. Serum hastalığı benzeri reaksiyonun tanı kriterleri bulunmamakla birlikte hastalığı tetikleyebilecek bir ajana maruziyetten 1-2 hafta sonra gelişen, başka bir nedene bağlanamayan ateş, döküntü, artrit-artralji, lenfadenopati, myalji kliniği ile tanı konulur. Serum hastalığı benzeri reaksiyonda önerilen ve görüş birliği sağlanmış bir tedavi şekli bulunmamaktadır. Bu konuyla ilgili literatürde daha çok yazarların kendi deneyimlerini paylaştıkları vaka bildirimleri mevcuttur.

🔖

Cite This Article

GÜNGÖRER, V., YORULMAZ, A., YÜKSEL, A., ARSLAN, Ş. (2020). Serum Sickness Like Disease in Children. Pediatric Practice and Research, Cilt: 8 - Sayı: 3, 116–121. https://ajindex.com/articles/795384

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Lundquist AL, Chari RS, Wood JH, et al. Serum sickness following rabbit antithymocyte globulin induction in a liver transplant recipient: case report and literature review. Liver Transpl. 2007;13: 647-50
  2. Gell PGH, Coombs RRA. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PGH, Coombs RRA, Hachmann PJ (eds). Clinical Aspects of Im - munology. Oxford, England: Blackwell Scientific Publications, 1975: 761-81
  3. Solensky R, Khan DA. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105:1-77
  4. Chen SM. Serum sickness. Emedicine Web site. http://www.emedicine. com/emerg/ Accessed February 19, 2008
  5. Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician. 2000;62(8):1823-1830, 1835-1836
  6. Von Pirquet CF, Schick B. Die Serum Krankheit. Franz Deutiche Leipzig Wien 1905. (English translation by Schick B:Serum Sickness. Baltimore: Williams & Wilkins, 1951
  7. Apisarnthanarak A, Uyeki TM, Miller ER, et al. Serum sickness-like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes. Clin Infect Dis. 2009; 49: 18
  8. Arkachaisri T. Serum sickness and hepatitis B vaccine including review of the literature. J Med Assoc Thai. 2002; 85 2: 607
  9. Misirlioglu ED, Duman H, Ozmen S, et al. Serum sickness-like reaction in children due to cefditoren. Pediatr Dermatol. 2012;29: 327-8
  10. Sohail MA, Nasir J, Ikram U, et al. Serum Sickness-Like Reaction with Clarithromycin. Journal of Hospital Medicine. 2011;6: 231–232
  11. Parshuram CS, Phillips RJ. Retrospective review of antibioticassociated serum sickness in children presenting to a paediatric emergency department. Med. J. Aust. 1998; 169: 116
  12. Levine LR. Quantitative comparison of adverse reactions to cefaclor vs amoxicillin in a surveillance study. Pediatr. Infect. Dis. J.1985; 4: 358–61
  13. Dyall D, Smith FACD. Serum sickness-like reaction. Dermatologist; 2009
  14. Doan T, Melvold R, Viselli S, et al. İmmünoloji Lippincott. Nobel Matbaacılık, 2013, İstanbul
  15. Barnes P. Pathophysiology of Allergic Inflammation. In: Franklin N, Adkinson JR. William WB. editors. Middleton’s Allergy E-Book: Principles and Practice. 8th edition, Vol 1, Section A, Chapter 21
  16. Katta R, Anusuri V. Serum sickness-like reaction to cefuroxime: a case report and review of the literature. J Drugs Dermatol. 2007; 6: 747–748
  17. Brucculeri M,